1 completed, 1 not yet recruiting, 1 recruiting. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 1, Not yet recruiting 1, Recruiting 1 |
| Phase 2 | 1 | Completed 1 |
Follow Post-traumatic Stress Disorder (PTSD): new trials by email Literature Review of Post-traumatic Stress Disorder (PTSD) trials Research Report on Post-traumatic Stress Disorder (PTSD)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Sleep Disturbances in Children and Adolescents With Post-traumatic Stress Disorder (PTSD): a Randomized Double-blind Placebo-controlled Trial to Investigate the Efficacy of Pediatric Prolonged-release Melatonin pediatric, prolonged released melatonin, Placebo - Post-traumatic Stress Disorder (PTSD), Current Significant Sleep Disturbances | Phase 3 | Not yet recruiting | University Hospital, Strasbourg, France | 120 | 2027-01-01 | 2026-02-18 |
| Effect of Psilocybin and Structured Integrated Reframing Therapy on Gut-Brain Axis Biomarkers and Depression in Major Depressive Disorder Psilocybin, Structured Integrated Reframing Therapy (SIRT), Selective Serotonin Reuptake Inhibitor (SSRI) - Major Depressive Disorder, Post-Traumatic Stress Disorder (PTSD) | Phase 3 | Recruiting | Khyber Medical University Peshawar | 60 | 2026-04-01 | 2026-07-14 |
| Progesterone Effect on Individuals Diagnoses With AD and PTSD. Progesterone, Placebo (for Progesterone) - Alcohol Dependence, Post-Traumatic Stress Disorder (PTSD) | Phase 2 / Phase 3 | Completed | Yale University | 13 | 2016-09-01 | 2023-04-26 |
Stress Disorders, Post-Traumatic (3) · Alcoholism (1) · Depressive Disorder, Major (1) · Wounds and Injuries (1)
Mental Disorders (3) · Stress Disorders, Traumatic (3) · Trauma and Stressor Related Disorders (3) · Alcohol-Related Disorders (1) · Chemically-Induced Disorders (1) · Depressive Disorder (1) · Mood Disorders (1) · Substance-Related Disorders (1)
Progesterone (1) · Psilocybin (1) · Selective Serotonin Reuptake Inhibitors (1)
Khyber Medical University Peshawar (1) · University Hospital, Strasbourg, France (1) · Yale University (1)
France (1) · Pakistan (1) · United States (1)
Dr Inayat Shah, PhD* (1) · Dr Omer Malik, PhD (1) · Elizabeth Ralevski, Ph.D. (1) · Naveeda Sarwar, PhD (1)